Inventor
LANSBURY PETER T
US20 patents
⚠️ This page may combine multiple inventors who share the name “LANSBURY PETER T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIAL—R&D INVEST S A
9 patentsUS11091492B2Aug 17, 2021
Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders
BIAL—R&D INVEST S A5 citations83
US11932645B2Mar 19, 2024
Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders
BIAL—R&D INVEST S A2 citations72
US11453675B2Sep 27, 2022
Imidazo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
BIAL—R&D INVEST S A2 citations72
US11400095B2Aug 2, 2022
Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
BIAL—R&D INVEST S A2 citations72
US11351173B2Jun 7, 2022
Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
BIAL—R&D INVEST S A3 citations72
US11345698B2May 31, 2022
Substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-a]pyrazines, related compounds, and their use in the treatment of medical disorders
BIAL—R&D INVEST S A3 citations72
US11168087B2Nov 9, 2021
Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders
BIAL—R&D INVEST S A4 citations72
US12116369B2Oct 15, 2024
Substituted pyrazolo[1,5-a]pyrimidines as glucocerebrosidase activators
BIAL—R&D INVEST S A0 citations62
US11878979B2Jan 23, 2024
Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b]pyridazines, related compounds, and their use in the treatment of medical disorders
BIAL—R&D INVEST S A1 citations62
LYSOSOMAL THERAPEUTICS INC
7 patentsUS10570135B2Feb 25, 2020
Substituted pyrazolo[1,5-A]pyrimidines and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC13 citations93
US9868742B2Jan 16, 2018
Substituted imidazo[1,2-b]pyridazines, substituted imidazo[1,5-b] pyridazines, related compounds, and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC17 citations93
US9920061B2Mar 20, 2018
Imidazo[1,5-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC16 citations92
US9840510B1Dec 12, 2017
Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC16 citations92
US9732089B2Aug 15, 2017
Substituted pyrazolo[1,5-a]pyrimidines and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC20 citations92
US10751341B2Aug 25, 2020
Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC12 citations85
US10786508B2Sep 29, 2020
Substituted imidazo[1,5-A]-pyrimidines and their use in the treatment of medical disorders
LYSOSOMAL THERAPEUTICS INC10 citations83
BIAL—BIOTECH INVEST INC
3 patentsUS10934298B2Mar 2, 2021
Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disorders
BIAL—BIOTECH INVEST INC10 citations84
US11192892B2Dec 7, 2021
Substituted pyrazolo[1,5-a]pyrimidines for the treatment of medical disorders
BIAL—BIOTECH INVEST INC4 citations72
US11124516B2Sep 21, 2021
Pyrrolo[1,2-A]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
BIAL—BIOTECH INVEST INC4 citations72